Skip to content
Stock screener

TCRT

Conviction 4HealthcareScan · Mon, Oct 12, 2026
Hammer

Alaunos Therapeutics, Inc. (TCRT) closed at $1.04 (+32.35%) on Oct 12, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 45, RS Rating 4, -76.1% from its 52-week high, -68.3% year to date. Sector: Healthcare · Pharmaceutical Preparations.

TCRT$1.04+32.35%
ResistanceSupportVol 14
63 bars

Price chart, 63 bars from Wed, Jul 15, 2026 to Mon, Oct 12, 2026. Last close $1.04, high $2.19, low $0.7190.

Vol MA14 226.77K
Jul 15Jul 31Aug 19Sep 4Sep 24Oct 12

Why TCRT moved

From the StockSetups movers recaps that covered TCRT, newest first. A recap states what was known that day.

Alaunos Therapeutics, Inc.Pharmaceutical Preparationswww.alaunos.com ↗
Price1.04
Change+32.35%
Gap+26.24%
Rel volume0.62×
Avg volume2.61M
Avg $ vol3.4M
SMA 201.05
SMA 501.49
SMA 2002.38
Price vs 50-30.14%
Price vs 200-56.35%
MA stackbearish
50/200 cross—
Supertrenddown · 1.12
RSI (14)45
MACD hist0.01
MACD crossbull · 0d
Stoch %K / %D58 / 26
ADX (14)52
+DI / −DI22 / 29
RSI divergence—
MACD divergence—
ATR %11.82%
ADR %13.46%
52w high4.36
52w low0.7424
From 52w high-76.15%
Above 52w low+40.09%
New 52w highNo
SqueezeOff
Bollinger width88.19%
%B0.49
Donchian pos34.48%
Donchian high1.65
Donchian low0.7190
AVWAP (52w high)1.42
vs AVWAP high-26.95%
AVWAP (52w low)0.9184
vs AVWAP low+13.24%
OBV trendDown
Chaikin MF (20)-0.01
Today vs 20d0.62×
Avg vol (14d)226.77K
Avg vol (20d)2.61M
Avg $ vol (20d)3.4M
Market cap2.64M
RS Rating4 / 99
RS 3m (vs SPY)-53.72%
RS 6m (vs SPY)-78.26%
RS line new highNo
Trend template1/8
Technical rank12.0
1 week+30.77%
1 month-31.13%
3 months-50.24%
6 months-64.86%
1 year-73.93%
YTD-68.29%
P/E-0.63
P/B4.05
P/S528.42
P/FCF-0.89
EPS-2.20
Div yield—
ROE-640.49%
ROA-275.46%
Debt/Eq0.00
Current0.77
EV/EBITDA-0.64
Gross margin—
Net margin—
Rev growth-50.00%
EPS growth10.75%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value2.52M
Revenue0
Net income-952K
Gross profit—
Free cash flow-2.97M
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out24.42M
Employees1
ListedWed, Aug 24, 2005
Free float1.87M
Float %77.7%
Short interest5.71K
Days to cover0.3d
Short volume56.0%
Squeeze score13 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank12.0 / 100
Group rank—
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in TCRT

All disclosures →
No recent disclosed trades by Congress in TCRT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TCRT

InsiderSideShares
Weis Holger
CEO · Common Stock · 2026-08-06
Grant4.36K
Vieser Jaime
Director · Common Stock · 2026-07-23
Grant8.79K
Postma Robert W
Director · Common Stock · 2026-07-23
Grant8.46K
Weis Holger
CEO · Common Stock · 2026-07-23
Grant4.57K
Jerman Michael Allen
Director · Common Stock · 2026-07-23
Grant8.14K
Weis Holger
Chief Executive Officer · Common Stock · 2026-06-12
Grant7.76K
Weis Holger
Chief Executive Officer · Common Stock · 2026-05-22
Grant3.7K
Postma Robert W
Director · Common Stock · 2026-04-29
Grant6.27K
Jerman Michael Allen
Director · Common Stock · 2026-04-29
Grant6.03K
Vieser Jaime
Director · Common Stock · 2026-04-29
Grant6.51K

SEC filings

EDGAR filings in TCRT · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.